Sectors
Novo and AbbVie-backed Reata plans to use the proceeds to fund a series of clinical trials for its hypertension treatments.
The oncology-focused biotechnology company, backed by Fidelity Management and Research, withdrew a previous filing in January 2015.
The energy management software producer has listed on the Australian Securities Exchange, providing an exit to Siemens and corporate-backed Aster Capital.
The marketing and game publishing company, which counts NetEase, Shanghai Media and Golden Eagle Broadcasting among its backers, has gone public in its home country of China.
The Visa and Starbucks-backed payment technology provider priced its shares at $9, a good deal below the $11 to $13 range set earlier this month.
The Cephalon-backed stem cell therapy developer had been listed in Australia since 2004, and also counts Celgene as a shareholder.
The Sanofi-backed gene therapy company floated below its $15 to $17 range, but its shares have since risen to $17.50.
Biopharmaceutical company Wave Life Sciences has gone public at the middle of its range just nine months after closing its $18m SNBL-led series A round.
Rocket Internet-backed meal delivery service HelloFresh hoped to raise around $332m from an initial public offering.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
